FDA Class I drug recalls
11 indexed U.S. FDA drug recall records carry the Class I classification, filed by 9 recalling firms across 9 FDA enforcement events, 2 of which cover more than one recall number, with report dates from 2026-05-13 to 2026-08-12. The median gap between a firm initiating one of these recalls and the FDA publishing it is 33 days. 8 of them (73%) print at least one NDC in the product description and 11 (100%) state a strength. Class I is the most serious of the three tiers the FDA uses when it classifies a recall action, and it is the tier regulatory-affairs and quality teams normally scan first. Every record below links to its own page and on to the verifiable openFDA source. This is a regulatory finding aid, not medical advice.
What this tier looks like in the indexed data
| Records in tier | 11 of the indexed recall records |
|---|---|
| Recalling firms | 9 |
| FDA events | 9 (2 covering >1 recall number) |
| Report date range | 2026-05-13 → 2026-08-12 |
| Median report lag | 33 days from initiation to report |
| Lifecycle statuses | 11 Ongoing |
| Country of record | United States (8) · Taiwan (2) · India (1) |
| Product forms | for Injection (2) · Solution (2) · Injection (2) · Tablets (1) · Gel (1) · Softgels (1) · Nasal Spray (1) · Cream (1) |
| Marketing category | Rx only (4) |
| With an NDC in the description | 8 (73%) |
| With a strength in the description | 11 (100%) |
Firms with Class I records
The 9 firms named on these records, most records first. Each links to the firm's regulatory profile, which aggregates its recall and shortage records across the indexed datasets. Counts are coverage-limited activity signals over the ingested window, never quality ratings.
Enforcement events covering more than one Class I recall number
The FDA files one event ID per enforcement action and one recall number per recalled product configuration, so a single action can appear as several records. These are the 2 multi-record events in this tier.
| Event ID | Recall numbers | Records |
|---|---|---|
| 99114 | 2 | D-0624-2026 · D-0625-2026 |
| 99437 | 2 | D-0743-2026 · D-0744-2026 |
Products named in more than one Class I record
Matched on the product-name prefix of the FDA's own product description, so different strengths and packages of the same product group together.
| Product | Records in this tier | Recall pages |
|---|---|---|
| Cyclophosphamide | 2 | D-0743-2026 · D-0744-2026 |
When these recalls were reported
Report-date months across the 11 records in this tier. The report date is when the FDA published the enforcement report, which is normally later than the date the firm began the recall.
| Report month | Class I records |
|---|---|
| 2026-08 | 2 |
| 2026-07 | 4 |
| 2026-06 | 3 |
| 2026-05 | 2 |
All Class I records (11)
Newest first by report date. Each row links to the record page, which carries the regulatory snapshot, the FDA's verbatim reason field, the identifiers extracted from the product description, and the other records that share its event, firm or product.
| Record | Type | Date |
|---|---|---|
| Cyclophosphamide for Injection | Sunny Pharmtech Inc. | 2026-08-12 |
| Cyclophosphamide for Injection | Sunny Pharmtech Inc. | 2026-08-12 |
| Cetirizine Hydrochloride Tablets USP 5 mg | JB Chemicals And Pharmaceuticals Ltd | 2026-07-29 |
| Revitaderm Wound Care Gel | Blaine Labs Inc | 2026-07-08 |
| BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) | Carefusion 213, LLC | 2026-07-01 |
| BD ChloraPrep FREPP Clear | Carefusion 213, LLC | 2026-07-01 |
| Gas-X Extra Strength | Haleon US Holdings LLC | 2026-06-17 |
| BEEKEEPER'S NATURALS Saline Nasal Spray | Beekeeper's Naturals Usa Inc. | 2026-06-17 |
| DOXOrubin Hydrochloride Liposome injection | Sun Pharmaceutical Industries Inc | 2026-06-17 |
| MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) | Wisconsin Pharmacal Company | 2026-05-27 |
| Lactated Ringer's Injection USP | B Braun Medical Inc | 2026-05-13 |
Other recall views
Class II recalls, Class III recalls, or the recall hub for the namespace-level counts, the enforcement-event index and the firm index. Field definitions are in the regulatory intelligence glossary; the data lineage is in the methodology and FDA data sources pages.
Source & provenance
- Official source
- https://open.fda.gov/apis/drug/enforcement/
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- Not available
- Ingested
- 2026-08-22
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.